Helen Rubinstein | Investor Relations |
Barry Greene | Chief Executive Officer |
Jim Doherty | Chief Development Officer |
Kimi Iguchi | Chief Financial Officer |
Chris Benecchi | Chief Commercial Officer |
Laura Chico | Wedbush |
Tiffany Sun | JPMorgan |
Ritu Baral | Cowen |
Yatin Suneja | Guggenheim |
Evan Hua | BMO Capital Markets |
Vamil Divan | Mizuho |
Neena Bitritto-Garg | Citi |
Sumant Kulkarni | Canaccord |
Lachlan Hanbury-Brown | William Blair |
Yasmeen Rahimi | Piper Sandler |
Good morning. Welcome to Sage Therapeutics' First Quarter 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors [Technical Difficulty] This call is the property of Sage Therapeutics and recording reduction or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited. Please note that this call is being recorded.